Ajitpal Singh Dhillon, PA-C

Ajitpal Dhillon practices at Hanford Specialty Surgery Center, PC in Hanford, California.

Ajitpal Dhillon's NPI, 1437520616, was assigned on October 13, 2015. Ajitpal Dhillon holds California license 52890.

Ajitpal Dhillon's primary practice is Hanford Specialty Surgery Center, PC, at 400 N Irwin St, Hanford, CA 93230 in Kings County. The practice phone is (800) 991-6448.

Ajitpal Dhillon's primary practice is Hanford Specialty Surgery Center, PC in Hanford, California. The medical group on file is Skin and Cancer Institute. Dmand AI also links Ajitpal Dhillon to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ajitpal Dhillon practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Ajitpal Dhillon's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Ajitpal Dhillon is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Ajitpal Dhillon is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, facial skin infection, itchy rashes, psoriasis and rash among the conditions Ajitpal Dhillon treats.

CMS data shows 2,176 Medicare services from Ajitpal Dhillon across 19 procedure codes in 2024, for 333 Medicare patients. Medicare paid $62,738 for them.

CMS counts 333 Medicare patients who saw Ajitpal Dhillon in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Ajitpal Dhillon's median patient age at 38, with 67% women.

In 2024, Ajitpal Dhillon wrote 301 Medicare Part D claims for 110 patients. 95% of them were for generic drugs. CMS names the drug for 169 of them, across 8 drugs with 11 or more claims each, at $7,765 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Ajitpal Dhillon for performance year 2024, reported as part of a group. Ajitpal Dhillon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 17 general payments to Ajitpal Dhillon from 8 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Incyte Corporation paid the most, $123.